Lipidomic Analysis Reveals the Protection Mechanism of GLP-1 Analogue Dulaglutide on High-Fat Diet-Induced Chronic Kidney Disease in Mice
Many clinical studies have suggested that glucagon-like peptide-1 receptor agonists (GLP-1RAs) have renoprotective properties by ameliorating albuminuria and increasing glomerular filtration rate in patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD) by lowering ectopic li...
Saved in:
Main Authors: | Martin Ho Yin Yeung (Author), Ka Long Leung (Author), Lai Yuen Choi (Author), Jung Sun Yoo (Author), Susan Yung (Author), Pui-Kin So (Author), Chi-Ming Wong (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The use of the GLP-1 analog - dulaglutide in the treatment of morbid obesity - case report
by: Agata Juda, et al.
Published: (2022) -
Single‐cell RNA sequencing and lipidomics reveal cell and lipid dynamics of fat infiltration in skeletal muscle
by: Ziye Xu, et al.
Published: (2021) -
Untargeted lipidomics reveals racial differences in lipid species among women
by: Ghazaleh Pourali, et al.
Published: (2024) -
Lipidomic Profiling Reveals Disruption of Lipid Metabolism in Valproic Acid-Induced Hepatotoxicity
by: Shansen Xu, et al.
Published: (2019) -
Global metabolomic and lipidomic analysis reveals the potential mechanisms of hemolysis effect of Ophiopogonin D and Ophiopogonin D' in vivo
by: Huan-Hua Xu, et al.
Published: (2021)